The Journal of urology
-
The Journal of urology · Jul 2015
Randomized Controlled TrialThe Impact of Pelvic Venous Pressure on Blood Loss during Open Radical Cystectomy and Urinary Diversion: Results of a Secondary Analysis of a Randomized Clinical Trial.
Blood loss and blood substitution are associated with higher morbidity after major abdominal surgery. During major liver resection low local venous pressure decreases blood loss. Ambiguity persists concerning the impact of local venous pressure on blood loss during open radical cystectomy. We determined the association between intraoperative blood loss and pelvic venous pressure as well as factors affecting pelvic venous pressure. ⋯ Blood loss was significantly decreased in patients with low pelvic venous pressure. Factors affecting pelvic venous pressure were fluid management and abdominal packing.
-
The Journal of urology · Jul 2015
Brain White Matter Abnormalities in Female Interstitial Cystitis/Bladder Pain Syndrome: A MAPP Network Neuroimaging Study.
Several chronic pain conditions may be distinguished by condition specific brain anatomical and functional abnormalities on imaging, which are suggestive of underlying disease processes. We present what is to our knowledge the first characterization of interstitial cystitis/bladder pain syndrome associated white matter (axonal) abnormalities based on multicenter neuroimaging from the MAPP Research Network. ⋯ To our knowledge we report the first characterization of brain white matter abnormalities in women with interstitial cystitis/bladder pain syndrome. Regional decreases and increases in white matter integrity across multiple axonal tracts were associated with symptom severity. Given that white matter abnormalities closely correlated with hallmark symptoms of interstitial cystitis/bladder pain syndrome, including bladder pain and urinary symptoms, brain anatomical alterations suggest that there are neuropathological contributions to chronic urological pelvic pain.
-
The Journal of urology · Jul 2015
Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis.
Erythrocytosis is the most common dose limiting adverse effect of testosterone therapy but the mechanisms of testosterone mediated erythropoiesis remain unclear. In this study we examine risk factors for erythrocytosis associated with testosterone therapy. ⋯ Dihydrotestosterone may have a role in testosterone therapy related erythrocytosis and monitoring dihydrotestosterone levels during testosterone therapy should be considered. In men in whom erythrocytosis develops, 5α-reductase inhibitors may be therapeutic.